Enhesa
Enhesa Appoints Keith Berry Chief Executive Officer
Enhesa announced a leadership change on September 9, 2026. Enhesa appointed Moody’s veteran Keith Berry CEO to advance its AI-powered regulatory intelligence and agentic compliance platform.
What changed
Keith Berry was named Chief Executive Officer. Peter Schramme will serve as Chief Strategy and Corporate Development Officer through 2026 before becoming Senior Board Advisor.
- Leader: Keith Berry
- Role: Chief Executive Officer
- Effective: September 9, 2026
- Announcement date: September 9, 2026
Leadership background
Berry spent 18 years at Moody’s and most recently served as General Manager of Third-Party Risk Management Solutions. Enhesa said he oversaw the creation of Moody’s first compliance AI agents and tripled revenue for the business unit.
The mandate
Berry will build on Enhesa’s expert-curated regulatory data with trusted, traceable AI and agentic capabilities that help global compliance teams monitor change and connect their own agents to the platform.
Why this matters for GTM teams
Executive appointments can precede changes in strategy, operating cadence, hiring, partnerships, and technology priorities. The useful signal is not the title alone: teams should watch the new leader’s stated mandate, prior playbook, organizational scope, and the initiatives announced during the first two quarters.
Source and methodology
This leadership profile is based on the company’s announcement. Roles, transition timing, and biographical details are presented as announced; SalesTools Research does not infer undisclosed succession plans.
Primary source: Enhesa leadership announcement.
Related Reports
Omnissa Appoints Amit Singh Chief Executive Officer
Omnissa appointed former Palo Alto Networks President Amit Singh CEO to lead AI-powered digital work and agentic endpoint strategy.
MongoDB Appoints Dev Ittycheria Interim CEO
MongoDB appointed former CEO Dev Ittycheria as interim President and CEO after Chirantan “CJ” Desai stepped down to take a senior role at Meta.
Slingshot Biosciences Appoints Dr. Nimisha Srivastava CEO
Slingshot Biosciences promoted Chief Operating Officer Dr. Nimisha Srivastava to CEO to lead commercial growth and product development.
Turn your sales ideas into reality today
Start your 14-day Pro trial today. No credit card required.
Start building for free